New cell therapy aims to slow vision loss in retinal disease
Disease control
Recruiting now
This early-stage study tests a new treatment called C.001 for people with retinal diseases that cause vision loss, such as geographic atrophy and Stargardt disease. The treatment is given as a single injection into the eye. The main goal is to check if it is safe, and researchers…
Phase: PHASE1 • Sponsor: Cellio Therapeutics Inc • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC